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inhibiting RhoA/ROCK pathway, suppressing RhoA activities, downregulating
associated proteins and interfering with the formation of stress ﬁbers.
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Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis
of ApoE-/-Mice Induced by Hyperlipaemia
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Objectives: Astragaloside IV (AsIV) is the major effective component extracted from
the Chinese herb Astragalus membranaceus, which has been widely used to treat
cardiovascular disease. Recent studies have shown that AsIV can potentially protect
the arteries from atherosclerosis, but the mechanisms of action are unknown. We
therefore examined the effects of AsIV on SDF-1, CXCR4 expressing content, SDF-1,
CXCR4 mRNA gene and protein expression in the high-fat diet ApoE-/- mice.
Methods: Thirty-nine 8-week-old male ApoE-/- mice were divided into Three groups:
model group, AMD3100 groups and AsIV group; Another Twelve 8-week-old inbred
C57BL/6 mice were used as the control group. Groups of mice were sacriﬁced at
12 weeks of treatment, the blood and the aorta were removed.TG, TC, HDL-C, LDL-
C levels of each group of mice were detected using large biochemical analyzer. Aortic
cross-section pathological damage of mice were detected using HE staining. Aortic
SDF-1, CXCR4 expression levels were quantiﬁed using western blotting and real-time
PCR. Protein and mRNA expression of the SDF-1, CXCR4 was quantiﬁed using
western blotting and real-time PCR. Using western blotting and real-time PCR to
quantify protein and mRNA expression of the bone marrow-derived endothelial
progenitor cells CXCR4 of in Each group mice.
Results: Biochemical analysis showed TG, TC, HDL-C and LDL-C levels in AsIV
group was signiﬁcantly better than that in Model group (P <0.05). The extent of
atherosclerosis in aortic of apoE-/-mice in AsIV group was signiﬁcantly lighter than
that in model group; and the SDF-1, CXCR4 expression of aortic reduced, showing
statistical signiﬁcance (P<0.05). Western blotting and real-time PCR demonstrated
Astragaloside IV signiﬁcantly down-regulated protein and mRNA expression of
SDF-1, CXCR4 (P<0.05 vs model group), showing statistical signiﬁcance. Consistent
with this, Astragaloside IV signiﬁcantly down-regulated protein and mRNA expres-
sion of CXCR4 of bone marrow-derived endothelial progenitor cell (P<0.05 vs model
group).
Conclusions: The protective effects of AsIV in atherosclerosis injury may be related
to the regulation of lipid metabolism disorders, down-regulation of SDF-1/CXCR4
biological axis expression. SDF-1/CXCR4 biological axis is probably one of targets
that astragaloside intervention atherosclerosis in ApoE-/- mice.
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Objectives: We investigated the relationship between the polymorphism of SOCS-3
and dyslipidemia of people from Uygur in Xinjiang, China.
Methods: This cross-sectional study included 1379 participants in a Hetian Xinjiang
Uygur population who were 30-70 years of age and were not from interracial mar-
riages of 3 generations; all subjects were genotyped (909 dyslipidemia subjects, 470
healthy subjects).
Results: Allele (P¼0.002) and genotype (P¼0.003) frequencies of the distribution of
rs12953258 was signiﬁcantly different between the dyslipidemia group and control
group. Between the total cholesterol (TC) abnormal group and control group, high-
density lipoprotein-cholesterol (HDL-C) abnormal group and control group, tri-
glycerides (TG) abnormal group and control group, the frequencies of genotype in
rs12953258 were signiﬁcantly different (P¼0.007, 0.012, 0.0004, respectively). Based
on the logistic regression analysis, genotype CA and AA of rs12953258 were inde-
pendent and risk factors for dyslipidemia in Uygur (CC vs CA; odds ratio¼1.48, 95%
conﬁdence interval 1.11-1.98, P¼0.008), (CC vs AA; odds ratio¼2.48, 95% conﬁ-
dence interval 1.07-5.79, P¼0.035). Genotype AA of rs12953258 merged with sub-
jects whose waist-hip ratio was abnormal, indicating the presence of dyslipidemia.
The frequency of haplotype 4 (H4) A-G-C in the dyslipidemia group was higher than
in the control group (8.44 vs 5.37%, P¼0.003).
Conclusions: rs12953258 site of the SOCS-3 gene showed a close relationship with
dyslipidemia in Uygur. Combining genotype AA with subjects whose waist-hip ratios
were abnormal will increase prevalence of dyslipidemia obviously.
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Objectives: To investigate the relationship between genetic polymorphisms of
SOCS3 and essential hypertension of Uygur Xinjiang population.C28 JACC Vol 64/16/Suppl C j OctobMethods: The study registed 921 Uygur (including 427 hypertension patients and 494
normotensives controls) from Hetian area hypertension epidemiological survey. The
representative determination of genotype variations were selected by TaqMan-PCR
method in Uygur subjects, the association between genetic variations of SOCS3 and
hypertension was analyzed by means of cross-sectional study.
Results: In the three representative variations genotyped, rs9914220, rs4969168,
rs12953258, all the research objects and control group were in Hardy-Weinberg
equilibrium for three polymorphisms. In population, there were signiﬁcant differ-
ences of genotype distribution between hypertension and control subjects in
rs9914220 polymorphisms (P¼0.009, P<0.001), and the frequency of CC was
signiﬁcantly higher than TT between hypertension patients and normotensives. But
there were no signiﬁcant differences of genotype distribution and allele frequencies
between two groups for rs4969168 and rs12953258 polymorphisms. After adjusted
by other risk factors for hypertension individuals in Uygur using logistic regression,
including age,body mass index (BMI), waist-hip ratio, fasting blood glucose (FBG),
Cholesterol (CHOL), Triglyceride (TG), low-density lipoprotein (LDL), high-density
lipoprotein (HDL), serum sodium, serum potassium, serum calcium,CC was still an
independent protective factor for hypertension in Uygur population (OR¼0.358,
95%CI 0.205-0.624, P¼0.021), so did CT (OR¼0.396, 95%CI 0.227-0.690,
P¼0.010). People more than 50 years old, male, overweight and obesity, High
triglycerides were signiﬁcant predictor factors associated with all hypertension
patients when comparing with controls. Further analysis found that the level of blood
pressure, LDL, total cholesterol, serum calcium related to homozygote TT were
higher than CC, that is to say the role of homozygote CC was reduce the risk of
hypertension.
Conclusions: This study reported that the SOCS3 gene may be one of the suscepti-
bility genes for essential hypertension. In the Uygur Xinjiang population, the carriers
of CC and CT genotypes at rs9914220 had reduced the level of blood pressure as well
as risks for essential hypertension.
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Objectives: Obstructive sleep apnea syndrome (OSAS) is strongly associated with the
increasing prevalence of cerebrovascular events and metabolic syndrome. A growing
number of studies have shown OSAS is an independent factor for insulin resistance,
glucose intolerance and type2 diabetes. However, relationship of OSAS with dysgly-
cemia is complex and still remains poorly understood. Glucose transporter 4 (GLUT4)
genes is Human and rodents’main glucose transporter sensitive to insulin, and therefore
conﬁrmation of candidate gene polymorphisms and association with OSAS is needed.
Aim of our study was to assess whether GLUT4 gene polymorphisms are associated
with OSAS.
Methods: Patients hospitalized at People’s Hospital of Xinjiang were selected from
January to December 2010. A total of 568 Han subjects who possibly exist OSAS base
on a history and physical examination were completed the polysomnography, 412of
whom (72.5%) were diagnosed with OSAS, and 156 individuals were conﬁrmed
without OSAS (27.5%). 96 severe OSAS patients chosen from OSAS were used for
DNA sequencing in functional domain. Blood samples were collected from all sub-
jects and genotyping was performed on DNA extracted from blood cells.
Results: We performed GLUT4 genome sequencing, found 4 mutated sites. And
ﬁnally selected three mutated sites such as rs5415, rs4517 and rs5435, according to
principle of linkage disequilibrium (r2 > 0.8) and minimum gene allele frequency
> 5%. All SNPs satisﬁed HEW (P > 0.05). Our study demonstrated a signiﬁcant
association of GLUT4 SNPrs5417 allele with OSAS, compared with controls
(P<0.05). Haplotype H1 (TCC) and H3 (CCC) deﬁned as SNPrs5415, rs4517 and
rs5435 are marginally associated with OSAS (P<0.05). Frequencies of C haplotype of
rs5417 in OSAS were higher than in controls. After adjustment for confounding
factors, (AC + AA) genotype signiﬁcantly reduces prevalence of OSAS, compared
with CC genotype. Level of awake blood oxygen and lowest blood oxygen of (AA +
AC) genotype was signiﬁcantly superior to those of CC genotype.
Conclusions: Our study demonstrates GLUT4 gene SNPrs5417 is associated with
OSAS in hypertensive population. Carriers of AA + AC have less prevalence of
obstructive sleep apnea syndrome than that of CC carriers.
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Objectives: Animal studies have demonstrated that scutellarin (SCU) limits damage
after myocardial ischemia injury. However, the underlying molecular mechanisms ofer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
